Animal microbiomes hold the key to new antifungals
From sea squirts to ants to opossums on the side of the road, the bacteria that live in animal microbiomes are a surprising source of new antifungals.
antifungals
A commercialization agreement for ibrexafungerp
Ibrexafungerp on track for FDA approval in June for vaginal yeast infections
Ibrexafungerp advances the fight against fungus
IV compound enters Phase 1, following FDA Priority Review and Fast Track designations for oral formulation
